Tenax Therapeutics, Inc. (TENX) Insider Trading Activity

NASDAQ$1.7748-0.07 (-3.80%)
Market Cap
$48.81M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
58 of 849
Rank in Industry
41 of 491

Largest Insider Buys in Sector

$350M
$217M
$172M
$109M
$107M
$104M

TENX Insider Trading Activity

TENX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$6,585,835
25
100
Sells
$0
0
0

Related Transactions

ADAR1 Capital Management, LLC10 percent owner
10
$6.26M
0
$0
$6.26M
Doogan Declandirector
1
$101,760
0
$0
$101,760
Rich StuartChief Medical Officer
5
$96,414
0
$0
$96,414
MCGAULEY THOMASInterim CFO
1
$58,164
0
$0
$58,164
Giordano Christopher ThomasCEO
5
$40,087
0
$0
$40,087
Almenoff June Sheriedirector
2
$14,945
0
$0
$14,945
STAAB THOMAS R IIChief Financial Officer
1
$10,981
0
$0
$10,981

About Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc. is a specialized pharmaceutical enterprise dedicated to discovering, advancing, and bringing to market therapies for cardiovascular and pulmonary conditions throughout the United States and Canada. Its product pipeline features TNX-103 and TNX-102 (levosimendan), both of which have successfully completed Phase II clinical trials. These compounds are being developed to manage pulmonary hypertension, particularly that linked to heart failure with preserved ejection fraction (HFpEF), as well as other forms of associated …

Insider Activity of Tenax Therapeutics, Inc.

Over the last 12 months, insiders at Tenax Therapeutics, Inc. have bought $6.59M and sold $0 worth of Tenax Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Tenax Therapeutics, Inc. have bought $3.3M and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: ADAR1 Capital Management, LLC (10 percent owner) — $6.26M. Doogan Declan (director) — $101,760. Rich Stuart (Chief Medical Officer) — $96,414.

The last purchase of 331,979 shares for transaction amount of $550,687 was made by ADAR1 Capital Management, LLC (10 percent owner) on 2026‑10‑21.

List of Insider Buy and Sell Transactions, Tenax Therapeutics, Inc.

2026-10-21PurchaseADAR1 Capital Management, LLC10 percent owner
331,979
1.2737%
$1.66
$550,687
+9.82%
2026-10-20PurchaseADAR1 Capital Management, LLC10 percent owner
254,342
0.9384%
$1.60
$405,726
+8.90%
2026-10-19PurchaseADAR1 Capital Management, LLC10 percent owner
336,528
1.2575%
$1.51
$507,013
+15.79%
2026-09-16PurchaseDoogan Declandirector
53,000
0.2108%
$1.92
$101,760
+1.37%
2026-09-15PurchaseGiordano Christopher ThomasCEO
4,850
0.0182%
$1.82
$8,837
+0.55%
2026-09-11PurchaseGiordano Christopher ThomasCEO
6,000
0.0119%
$1.88
$11,250
-1.08%
2026-09-11PurchaseSTAAB THOMAS R IIChief Financial Officer
5,675
0.0116%
$1.94
$10,981
-1.08%
2026-09-03PurchaseADAR1 Capital Management, LLC10 percent owner
900,000
1.7716%
$1.78
$1.6M
+4.49%
2026-09-02PurchaseADAR1 Capital Management, LLC10 percent owner
187,704
0.6879%
$1.80
$337,586
+0.54%
2026-09-01PurchaseADAR1 Capital Management, LLC10 percent owner
179,058
0.6735%
$1.80
$321,570
+3.06%
2026-08-31PurchaseADAR1 Capital Management, LLC10 percent owner
403,571
0.772%
$1.79
$722,594
+0.54%
2026-08-24PurchaseADAR1 Capital Management, LLC10 percent owner
107,374
0.2001%
$1.75
$188,355
+0.54%
2026-08-21PurchaseADAR1 Capital Management, LLC10 percent owner
716,369
1.4224%
$1.77
$1.27M
+6.29%
2026-08-20PurchaseADAR1 Capital Management, LLC10 percent owner
202,124
0.3971%
$1.78
$359,538
+4.21%
2025-12-09PurchaseRich StuartChief Medical Officer
2,500
0.0574%
$10.22
$25,542
+24.42%
2025-12-08PurchaseRich StuartChief Medical Officer
2,500
0.0537%
$10.10
$25,251
+18.93%
2025-12-04PurchaseRich StuartChief Medical Officer
2,500
0.0539%
$9.20
$22,998
+30.37%
2025-12-03PurchaseRich StuartChief Medical Officer
1,500
0.0325%
$9.08
$13,618
+32.59%
2025-12-02PurchaseRich StuartChief Medical Officer
1,000
0.0219%
$9.01
$9,006
+35.18%
2025-11-20PurchaseGiordano Christopher ThomasCEO
538
0.0116%
$7.59
$4,083
+56.42%
Total: 55
*Gray background shows transactions not older than one year

Insider Historical Profitability

39.61%
ADAR1 Capital Management, LLC10 percent owner
7447000
28.0752%
$13.7M100
Doogan Declandirector
55274
0.2084%
$101,704.1610
Giordano Christopher ThomasCEO
22174
0.0836%
$40,800.1650
STAAB THOMAS R IIChief Financial Officer
15675
0.0591%
$28,842.0010
Rich StuartChief Medical Officer
5266
0.0199%
$9,689.4450
MCGAULEY THOMASInterim CFO
5000
0.0189%
$9,200.0010
Almenoff June Sheriedirector
1993
0.0075%
$3,667.1220
ARMISTICE CAPITAL, LLC
2019995
7.6154%
$3.72M130
Kiral Richard MPresident
104995
0.3958%
$193,190.8030
Mitchum James P.director
19000
0.0716%
$34,960.0020
Jebsen Michael BCFO
9336
0.0352%
$17,178.2430
BLANCK RONALD Rdirector
6062
0.0229%
$11,154.0841
Davidson Michael H.director
2881
0.0109%
$5,301.0410
+39.61%
PROEHL GERALD Tdirector
1667
0.0063%
$3,067.2830
+39.61%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$84,911,583
59
17.82%
$37.44M
$103,288,323
51
4.78%
$56.52M
$693,326
47
-16.24%
$40.24M
$24,478,755
37
-34.59%
$53.59M
$115,646,156
35
16.45%
$54.05M

TENX Institutional Investors: Active Positions

Increased Positions30+100%3M+57.2%
Decreased Positions8-26.67%471,886-10%
New Positions18New2MNew
Sold Out Positions5Sold Out460,344Sold Out
Total Postitions52+73.33%7M+47.2%

TENX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Ikarian Capital, Llc$10,692.0016.13%967,600+967,600New2025-09-30
Vr Adviser, Llc$4,837.007.3%437,708+339,144+344.08%2025-09-30
Rtw Investments, Lp$4,181.006.31%378,34600%2025-09-30
Siren, L.L.C.$3,894.005.87%352,441+352,441New2025-09-30
Boothbay Fund Management, Llc$3,892.005.87%352,206+352,206New2025-09-30
Bvf Inc/Il$3,752.005.66%339,54900%2025-09-30
Millennium Management Llc$3,467.005.23%313,712+79,998+34.23%2025-09-30
Vivo Capital, Llc$2,302.003.47%208,33300%2025-09-30
Morgan Stanley$1,971.002.97%178,329+319+0.18%2025-09-30
Marshall Wace, Llp$1,958.002.95%177,209+177,209New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.